Oral Abstract Session:
095. Use 'em and Lose 'em: Preventing Antibiotic Overuse
Thursday, October 5, 2017: 2:00 PM-3:30 PM
Room: 05AB

Tracks: Pediatric ID, Investigative ID, Adult ID


Moderators:  E. Yoko Furuya, MD, MS, Columbia University Medical Center and Usha Stiefel, M.D., Case Western Reserve University School of Medicine

Presentations:
2:00 PM
891
Antibiotic Consumption and Antibiotic Resistance across Organisms, Drugs, and Consumer Groups
Scott Olesen, PhD; Michael Barnett, MD, MS; Derek MacFadden, MD; Marc Lipsitch, DPhil; Yonatan H. Grad, MD, PhD
2:15 PM
892
Improvement of Gram Negative Susceptibility to Fluoroquinolones After Implementation of a Pre-Authorization Policy for Fluoroquinolone Use: A Decade-Long Experience
Rachael A. Lee, MD; Morgan Scully, MD; Danielle F. Kunz, PharmD; T. Aaron Jones, PharmD; Bernard Camins, MD, MSc; Todd P McCarty, MD; Stephen Moser, PhD; Craig J Hoesley, MD; Peter G Pappas, MD
2:30 PM
893
Inpatient plus post-discharge durations of therapy to identify antimicrobial stewardship opportunities at transitions of care
April Dyer, PharmD, MBA, MSCR, BCPS; Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS; Deverick J. Anderson, MD, MPH, FIDSA, FSHEA; Christina Sarubbi, PharmD; Rebekah Wrenn, PharmD; Lauri Hicks, DO; Arjun Srinivasan, MD, FSHEA; Rebekah W. Moehring, MD, MPH
2:45 PM
894
Prevent Antibiotic overUSE (PAUSE): Impact of a provider driven antibiotic-time out on antibiotic use and prescribing
Kerri Thom, MD, MS; Pranita Tamma, MD, MHS; Anthony D. Harris, MD, MPH; Daniel Morgan, MD, MS, FIDSA, FSHEA; Kathryn Dzintars, PharmD; Arjun Srinivasan, MD, FSHEA; Edina Avdic, MBA, PharmD, BCPS AQ-ID; David X. Li, MD; Lisa Pineles, MA; Sara E. Cosgrove, MD, MS
3:00 PM
895
Implementing Antimicrobial Stewardship in Two Community Nepali Hospitals
Michael P Veve, PharmD; Linda M Kaljee, PhD; Tyler Prentiss, B.S.; Rajesh Dhoj Joshi, MD; Shankar Man Rai, MD; Basudha Shrestha, PhD; Deepak Chandra Bajracharya, PC; Marcus J Zervos, MD
3:15 PM
896
The Ontario Program To Improve AntiMIcrobial USE (OPTIMISE): A Descriptive Analysis of Dispensed Antibiotics
Kevin Schwartz, MD, MSc; Camille Achonu, MHSc,; Kevin Brown, PhD; Gary Garber, MD, FACP, FIDSA; Jennie Johnstone, MD, PhD; Bradley Langford, BScPhm ACPR PharmD BCPS; Valerie Leung, BscPhm, ACPR; Nick Daneman, MD, MSc

CME Credits: No CME credit is offered for this session.


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.